Premier Cancer Institute, The Royal Marsden NHS Foundation Trust, Employs AI in Pioneering Cancer Research in Collaboration with NTT DATA and CARPL.ai
The Royal Marsden and NTT DATA Partner to Revolutionize Cancer Care with AI
In a groundbreaking development, The Royal Marsden NHS Foundation Trust, a world-leading specialist cancer center, has partnered with NTT DATA and CARPL.ai to create an AI-powered radiology analysis service for cancer research. This collaboration aims to enhance the speed and accuracy of cancer detection, ultimately improving patient outcomes.
The partnership is focused on leveraging advanced AI technologies, specifically generative AI (Gen AI), to strengthen radiology analysis for cancer detection and treatment planning within the NHS. The Royal Marsden and NTT DATA are co-developing an AI system that performs advanced radiology analysis, aiding clinicians by providing imaging biomarker analysis, critical for precise cancer diagnostics and personalized treatment strategies.
This initiative aligns with the UK Government’s 10-Year Health Plan for England, which aims to transform the NHS into the most AI-enabled health system globally. The plan emphasizes the importance of trusted AI assistants to support healthcare professionals, improve diagnostic decisions, and address workforce skill gaps.
The project is funded by a three-year grant from the UK’s National Institute for Health and Care Research (NIHR), ensuring rigorous standards of secure and ethical AI application in healthcare. The aim is to push the boundaries of cancer research responsibly, prioritizing patient outcomes and data security.
While specific details about CARPL.ai’s contributions are limited, the company is mentioned as a key partner in this AI-driven cancer detection ecosystem, likely providing specialized AI technology or expertise in medical imaging analytics as part of this integrated service.
By combining AI capabilities with clinical expertise at The Royal Marsden, this service aims to accelerate the diagnostic process, leading to earlier cancer detection and more targeted treatments. The service is designed to improve the accuracy of cancer evaluation, including sarcoma, lung, breast, brain, and prostate cancers.
The Royal Marsden, with its affiliation with The Institute of Cancer Research (ICR), is the UK’s only National Institute for Health and Care Research (NIHR) Biomedical Research Centre (BRC) dedicated solely to cancer. This partnership exemplifies how AI is transforming cancer care within the NHS by integrating cutting-edge technology into established clinical workflows, backed by national strategic health initiatives and research funding.
As the service continues to develop, it is expected to provide significant benefits to cancer patients, accelerating early diagnosis, and ensuring treatment and care are personalized for the needs of each individual. The collaboration between The Royal Marsden, NTT DATA, and CARPL.ai is a testament to the power of technology and collaboration in advancing cancer care and improving patient outcomes.
[1] The Royal Marsden NHS Foundation Trust. (n.d.). AI-Powered Radiology Analysis Service for Cancer Research. Retrieved from https://www.royalmarsden.nhs.uk/research/ai-powered-radiology-analysis-service-for-cancer-research
[2] NHS England. (2021). NHS Long Term Plan: AI in Healthcare and Care. Retrieved from https://www.england.nhs.uk/ourwork/ai-health-and-care/ai-in-healthcare-and-care/ai-in-healthcare-and-care-long-term-plan/
[3] National Institute for Health and Care Research. (n.d.). NIHR Biomedical Research Centre (BRC) at The Royal Marsden and The Institute of Cancer Research (ICR). Retrieved from https://www.nihr.ac.uk/our-research/biomedical-research-centres/brc-at-the-royal-marsden-and-the-institute-of-cancer-research-icr/30267
- The co-developed AI system between The Royal Marsden and NTT DATA will be deployed in the cloud, leveraging its infrastructure for advanced radiology analysis to detect and treat various medical conditions, such as sarcoma, lung, breast, brain, and prostate cancers.
- The UK Government's 10-Year Health Plan for England emphasizes the integration of AI technology like the one being developed by The Royal Marsden and NTT DATA, as part of its strategy to create a global leader in AI-enabled healthcare services and address potential workforce skill gaps.
- The prospective integration of advanced AI technologies, like generative AI (Gen AI), into the healthcare infrastructure holds the potential for numerous news stories, showcasing the progress and impact of science and technology on medical-conditions research and treatment strategies.
